Again, a study by Narayan et al. (30) has found that RARB promoter methylation was associated with cervical cancer prognosis, i.e., 80% of the patients with RARB hypermethylation either died of cancer or only partly responded to treatment. Here, RARB is linked to cervical carcinoma.